QUEBEC CITY — Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), announced that the TSX Venture Exchange (the “Exchange”) has approved its application for reinstatement of trading of the Company’s common shares on the Exchange effective April 30, 2025. This follows the successful resolution of the Failure-to-File Cease Trade Order (the […]